$64.68
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 7 | 8 | 8 |
Hold | 1 | 1 | 1 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Viking Therapeutics, Inc. (VKTX) is $113.36, offered by 17 analysts offering 12-month price forecasts.
Viking Therapeutics, Inc. (VKTX) has a maximum of 0.75 upside potential, based on 17 analysts offering 12-month price forecasts.
Based on 17 analysts tracking and researching Viking Therapeutics, Inc. (VKTX), 94.12% have a buy recommendation. Remaining 5.88% have either sell or hold recommendations.
The latest share price of Viking Therapeutics, Inc. (VKTX) is $64.68 as of 26/07/2024.
16 of total 17 analysts offering stock ratings for Viking Therapeutics, Inc. VKTX have recommended buy rating.